Dive Brief: Fresh off the dedication of a major new building in Boston’s Seaport, Vertex Pharmaceuticals said it’s making plans for yet another facility that …
Dive Brief: Orchard Therapeutics, a London- and Boston-based developer of gene therapies, plans to lay off 30% of its workforce, or about 65 employees, as …
